CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Carcinoma, Breast
Interventions: DRUG: 0.04 mg/kg CpG 7909|DRUG: Herceptin®|DRUG: 0.08 mg/kg CpG 7909|DRUG: Herceptin®|DRUG: 0.12 mg/kg CpG 7909|DRUG: Herceptin®|DRUG: 0.16 mg/kg CpG 7909|DRUG: Herceptin®
Sponsor: Pfizer